Agmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemia

Jae Hwan Kim, Yong Woo Lee, Kyung Ah Park, Won Taek Lee, Jong Eun Lee

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Brain edema is frequently shown after cerebral ischemia. It is an expansion of brain volume because of increasing water content in brain. It causes to increase mortality after stroke. Agmatine, formed by the decarboxylation of L-arginine by arginine decarboxylase, has been shown to be neuroprotective in trauma and ischemia models. The purpose of this study was to investigate the effect of agmatine for brain edema in ischemic brain damage and to evaluate the expression of aquaporins (AQPs). Results showed that agmatine significantly reduced brain swelling volume 22 h after 2 h middle cerebral artery occlusion in mice. Water content in brain tissue was clearly decreased 24 h after ischemic injury by agmatine treatment. Blood-brain barrier (BBB) disruption was diminished with agmatine than without. The expressions of AQPs-1 and-9 were well correlated with brain edema as water channels, were significantly decreased by agmatine treatment. It can thus be suggested that agmatine could attenuate brain edema by limitting BBB disruption and blocking the accumulation of brain water content through lessening the expression of AQP-1 after cerebral ischemia.

Original languageEnglish
Pages (from-to)943-949
Number of pages7
JournalJournal of Cerebral Blood Flow and Metabolism
Volume30
Issue number5
DOIs
Publication statusPublished - 2010 May 1

Fingerprint

Agmatine
Aquaporin 1
Brain Edema
Brain Ischemia
Brain
Aquaporins
Blood-Brain Barrier
Water
Decarboxylation
Middle Cerebral Artery Infarction
Wounds and Injuries
Arginine
Ischemia
Stroke
Mortality

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Kim, Jae Hwan ; Lee, Yong Woo ; Park, Kyung Ah ; Lee, Won Taek ; Lee, Jong Eun. / Agmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemia. In: Journal of Cerebral Blood Flow and Metabolism. 2010 ; Vol. 30, No. 5. pp. 943-949.
@article{39ae5a5a2c0c451c9ed6d46211838851,
title = "Agmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemia",
abstract = "Brain edema is frequently shown after cerebral ischemia. It is an expansion of brain volume because of increasing water content in brain. It causes to increase mortality after stroke. Agmatine, formed by the decarboxylation of L-arginine by arginine decarboxylase, has been shown to be neuroprotective in trauma and ischemia models. The purpose of this study was to investigate the effect of agmatine for brain edema in ischemic brain damage and to evaluate the expression of aquaporins (AQPs). Results showed that agmatine significantly reduced brain swelling volume 22 h after 2 h middle cerebral artery occlusion in mice. Water content in brain tissue was clearly decreased 24 h after ischemic injury by agmatine treatment. Blood-brain barrier (BBB) disruption was diminished with agmatine than without. The expressions of AQPs-1 and-9 were well correlated with brain edema as water channels, were significantly decreased by agmatine treatment. It can thus be suggested that agmatine could attenuate brain edema by limitting BBB disruption and blocking the accumulation of brain water content through lessening the expression of AQP-1 after cerebral ischemia.",
author = "Kim, {Jae Hwan} and Lee, {Yong Woo} and Park, {Kyung Ah} and Lee, {Won Taek} and Lee, {Jong Eun}",
year = "2010",
month = "5",
day = "1",
doi = "10.1038/jcbfm.2009.260",
language = "English",
volume = "30",
pages = "943--949",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "5",

}

Agmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemia. / Kim, Jae Hwan; Lee, Yong Woo; Park, Kyung Ah; Lee, Won Taek; Lee, Jong Eun.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 30, No. 5, 01.05.2010, p. 943-949.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Agmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemia

AU - Kim, Jae Hwan

AU - Lee, Yong Woo

AU - Park, Kyung Ah

AU - Lee, Won Taek

AU - Lee, Jong Eun

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Brain edema is frequently shown after cerebral ischemia. It is an expansion of brain volume because of increasing water content in brain. It causes to increase mortality after stroke. Agmatine, formed by the decarboxylation of L-arginine by arginine decarboxylase, has been shown to be neuroprotective in trauma and ischemia models. The purpose of this study was to investigate the effect of agmatine for brain edema in ischemic brain damage and to evaluate the expression of aquaporins (AQPs). Results showed that agmatine significantly reduced brain swelling volume 22 h after 2 h middle cerebral artery occlusion in mice. Water content in brain tissue was clearly decreased 24 h after ischemic injury by agmatine treatment. Blood-brain barrier (BBB) disruption was diminished with agmatine than without. The expressions of AQPs-1 and-9 were well correlated with brain edema as water channels, were significantly decreased by agmatine treatment. It can thus be suggested that agmatine could attenuate brain edema by limitting BBB disruption and blocking the accumulation of brain water content through lessening the expression of AQP-1 after cerebral ischemia.

AB - Brain edema is frequently shown after cerebral ischemia. It is an expansion of brain volume because of increasing water content in brain. It causes to increase mortality after stroke. Agmatine, formed by the decarboxylation of L-arginine by arginine decarboxylase, has been shown to be neuroprotective in trauma and ischemia models. The purpose of this study was to investigate the effect of agmatine for brain edema in ischemic brain damage and to evaluate the expression of aquaporins (AQPs). Results showed that agmatine significantly reduced brain swelling volume 22 h after 2 h middle cerebral artery occlusion in mice. Water content in brain tissue was clearly decreased 24 h after ischemic injury by agmatine treatment. Blood-brain barrier (BBB) disruption was diminished with agmatine than without. The expressions of AQPs-1 and-9 were well correlated with brain edema as water channels, were significantly decreased by agmatine treatment. It can thus be suggested that agmatine could attenuate brain edema by limitting BBB disruption and blocking the accumulation of brain water content through lessening the expression of AQP-1 after cerebral ischemia.

UR - http://www.scopus.com/inward/record.url?scp=77952011417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952011417&partnerID=8YFLogxK

U2 - 10.1038/jcbfm.2009.260

DO - 10.1038/jcbfm.2009.260

M3 - Article

C2 - 20029450

AN - SCOPUS:77952011417

VL - 30

SP - 943

EP - 949

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 5

ER -